3320

COM:CRPHARM

华润医药集团有限公司

  • Stock

Last Close

5.33

22/11 08:08

Market Cap

34.24B

Beta: -

Volume Today

12.67M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
13.95B
-
15.48B
10.94%
17.06B
10.17%
20.13B
18.04%
21.47B
6.63%
21.93B
2.16%
23.46B
6.97%
27.14B
15.68%
29.70B
9.46%
30.80B
3.68%
average payables
27.76B
-
32.11B
15.65%
36.62B
14.05%
41.01B
11.99%
40.85B
0.39%
41.12B
0.66%
44.21B
7.52%
49.04B
10.91%
53.54B
9.17%
39.18B
26.82%
average receivables
44.55B
-
52.18B
17.12%
56.07B
7.46%
64.13B
14.39%
66.52B
3.73%
31.03B
53.36%
89.11B
-
book value per share
2.91
-
3.32
14.05%
3.65
9.68%
7.66
110.07%
6.66
13.00%
6.27
5.96%
6.48
3.40%
7.40
14.17%
8.11
9.72%
7.89
2.79%
7.32
7.26%
capex per share
-0.49
-
-0.52
6.45%
-0.39
24.88%
-0.37
3.96%
-0.32
14.45%
-0.31
1.28%
-0.32
3.16%
-0.35
8.75%
-0.50
41.81%
-0.55
10.82%
capex to depreciation
-2.51
-
-2.36
5.92%
-1.78
24.50%
-1.44
19.28%
-1.28
10.92%
-1.22
4.38%
-0.86
29.48%
-0.91
5.20%
-1.11
22.81%
-1.11
0.79%
capex to operating cash flow
-0.73
-
-0.76
4.30%
-0.40
47.49%
-0.44
11.11%
-0.41
7.19%
-0.24
41.85%
-0.25
4.51%
-0.27
7.86%
-0.24
9.40%
-0.28
12.68%
capex to revenue
-0.03
-
-0.02
8.29%
-0.02
30.43%
-0.01
28.51%
-0.01
0.60%
-0.01
10.20%
-0.01
4.29%
-0.01
10.91%
-0.01
20.01%
-0.01
3.27%
cash per share
2.74
-
3.08
12.20%
3.03
1.63%
3.58
18.39%
3.30
8.03%
7.11
115.54%
6.19
12.83%
7.30
17.80%
9.19
26.01%
8.29
9.84%
5.04
39.19%
days of inventory on hand
45.99
-
50.19
9.12%
45.12
10.09%
51.91
15.05%
54.16
4.33%
50.77
6.26%
47.83
5.81%
53.37
11.60%
53.80
0.80%
50.46
6.21%
56.38
11.73%
days payables outstanding
93.21
-
98.41
5.57%
98.85
0.46%
109.63
10.90%
106.75
2.63%
93.18
12.71%
91.51
1.79%
99.21
8.41%
94.92
4.32%
92.86
2.17%
68.34
26.40%
days sales outstanding
123.61
-
133.07
7.66%
136.62
2.66%
133.40
2.36%
150.20
12.59%
119.40
20.50%
112.77
-
debt to assets
0.30
-
0.31
2.74%
0.29
4.32%
0.19
34.44%
0.23
19.54%
0.29
25.99%
0.22
24.86%
0.21
2.88%
0.23
7.87%
0.22
4.94%
0.31
44.52%
debt to equity
1.74
-
1.82
4.66%
1.65
8.93%
0.68
58.68%
0.88
28.86%
1.29
46.89%
1.01
21.65%
0.95
6.26%
1.11
16.73%
1.05
5.08%
1.68
59.39%
dividend yield
0.01
-
0.01
21.03%
0.02
67.06%
0.03
53.31%
0.03
22.62%
0.02
29.79%
earnings yield
0.05
-
0.05
0.24%
0.05
7.72%
0.07
28.08%
0.05
16.56%
0.06
14.80%
0.11
78.46%
0.21
89.27%
0.30
40.36%
0.20
33.72%
0.12
39.46%
enterprise value
71.66B
-
79.46B
10.89%
80.45B
1.25%
54.74B
31.97%
86.31B
57.69%
98.53B
14.16%
74.18B
24.72%
57.99B
21.82%
61.34B
5.77%
74.84B
22.02%
78.53B
4.93%
enterprise value over ebitda
7.38
-
7.79
5.52%
7.82
0.41%
4.93
36.93%
6.92
40.35%
7.14
3.13%
6.13
14.11%
4.29
29.98%
4.22
1.73%
4.54
7.55%
5.64
24.32%
ev to operating cash flow
17.47
-
18.98
8.65%
13.43
29.22%
13.29
1.10%
17.77
33.74%
11.95
32.76%
9.11
23.73%
7.07
22.44%
4.78
32.42%
5.93
24.06%
ev to sales
0.61
-
0.59
4.46%
0.55
6.22%
0.35
36.37%
0.50
43.22%
0.52
3.83%
0.36
30.15%
0.29
20.25%
0.26
10.48%
0.29
13.71%
0.32
8.96%
free cash flow per share
0.18
-
0.16
9.81%
0.58
260.03%
0.47
19.97%
0.45
2.53%
1.00
119.65%
0.97
2.69%
0.95
1.82%
1.54
61.96%
1.46
5.69%
free cash flow yield
0.02
-
0.02
9.81%
0.06
260.03%
0.05
17.59%
0.04
15.73%
0.10
117.51%
0.13
37.55%
0.24
77.90%
0.43
82.03%
0.23
47.03%
graham net net
-3.15
-
-3.35
6.36%
-3.21
4.02%
-1.97
38.64%
-2.06
4.43%
-2.19
6.24%
-11.19
411.43%
-11.33
1.24%
-12.89
13.72%
-13.40
3.95%
-7.88
41.20%
graham number
5.30
-
5.66
6.93%
6.15
8.69%
9.95
61.65%
9.11
8.37%
9.52
4.41%
10.87
14.25%
11.87
9.20%
13.90
17.05%
14.89
7.10%
10.05
32.49%
income quality
0.59
-
0.60
1.92%
0.74
23.01%
0.51
31.15%
0.57
10.50%
0.89
57.65%
1.23
37.42%
1.16
5.41%
1.53
31.69%
1.28
16.09%
intangibles to total assets
0.20
-
0.18
10.62%
0.18
2.47%
0.18
3.75%
0.17
0.73%
0.16
10.74%
0.13
13.77%
0.13
0.06%
0.14
2.24%
0.13
5.12%
0.09
33.08%
interest coverage
4.81
-
4.15
13.76%
4.36
5.19%
5.47
25.41%
4.89
10.64%
4.17
14.68%
2.62
37.12%
3.51
33.83%
4.27
21.66%
4.68
9.51%
4.50
3.77%
interest debt per share
5.34
-
6.38
19.44%
6.36
0.33%
5.60
11.98%
6.22
11.13%
8.57
37.72%
7.16
16.49%
7.53
5.21%
9.44
25.34%
8.76
7.18%
12.66
44.49%
inventory turnover
7.94
-
7.27
8.36%
8.09
11.23%
7.03
13.08%
6.74
4.15%
7.19
6.67%
7.63
6.16%
6.84
10.39%
6.78
0.79%
7.23
6.62%
6.47
10.50%
invested capital
1.74
-
1.82
4.66%
1.65
8.93%
0.68
58.68%
0.88
28.86%
1.29
46.89%
1.01
21.65%
0.95
6.26%
1.11
16.73%
1.05
5.08%
1.68
59.39%
market cap
55.61B
-
55.61B
0%
55.61B
0%
42.98B
22.71%
63.60B
47.96%
64.23B
0.99%
45.44B
29.26%
25.07B
44.83%
22.30B
11.04%
39.71B
78.03%
32.23B
18.83%
net current asset value
-3.38B
-
-369.96M
89.04%
1.55B
520.01%
14.12B
808.63%
15.58B
10.36%
12.64B
18.85%
12.50B
1.15%
17.77B
42.14%
23.03B
29.63%
19.35B
16.00%
24.77B
28.04%
net debt to ebitda
1.65
-
2.34
41.46%
2.41
3.30%
1.06
56.14%
1.82
72.03%
2.48
36.44%
2.38
4.41%
2.44
2.59%
2.68
10.16%
2.13
20.66%
3.33
56.12%
net income per share
0.43
-
0.43
0.24%
0.46
7.72%
0.57
24.39%
0.55
3.50%
0.64
15.93%
0.81
26.25%
0.85
4.45%
1.06
24.88%
1.25
17.99%
0.61
50.86%
operating cash flow per share
0.66
-
0.68
2.06%
0.97
43.04%
0.84
13.57%
0.77
7.83%
1.31
69.78%
1.30
1.29%
1.31
0.83%
2.04
56.51%
2.01
1.65%
payables turnover
3.92
-
3.71
5.28%
3.69
0.45%
3.33
9.83%
3.42
2.70%
3.92
14.56%
3.99
1.83%
3.68
7.76%
3.85
4.52%
3.93
2.22%
5.34
35.87%
receivables turnover
2.95
-
2.74
7.11%
2.67
2.59%
2.74
2.41%
2.43
11.19%
3.06
25.79%
3.24
-
research and ddevelopement to revenue
0.01
-
return on tangible assets
0.03
-
0.03
15.94%
0.03
3.74%
0.03
6.84%
0.03
2.73%
0.03
3.40%
0.03
14.20%
0.03
5.23%
0.03
5.54%
0.04
20.57%
0.02
54.21%
revenue per share
18.95
-
21.99
16.07%
23.75
7.97%
31.90
34.34%
27.45
13.94%
30.18
9.94%
32.53
7.78%
31.90
1.95%
37.69
18.16%
40.45
7.31%
38.95
3.70%
roe
0.15
-
0.13
12.11%
0.13
1.79%
0.07
40.79%
0.08
10.92%
0.10
23.28%
0.13
22.10%
0.11
8.51%
0.13
13.82%
0.16
21.38%
0.08
47.01%
roic
0.14
-
0.12
10.99%
0.11
6.89%
0.12
1.74%
0.11
3.74%
0.11
0.58%
0.09
20.37%
0.09
1.44%
0.08
5.62%
0.10
21.17%
0.07
34.43%
sales general and administrative to revenue
0.03
-
0.03
0.40%
0.03
16.15%
0.02
5.56%
0.02
0.64%
0.03
2.66%
0.03
0.72%
0.03
9.08%
0.03
5.15%
0.03
3.18%
shareholders equity per share
2.91
-
3.32
14.05%
3.65
9.68%
7.66
110.07%
6.66
13.00%
6.27
5.96%
6.48
3.40%
7.40
14.17%
8.11
9.72%
7.89
2.79%
7.32
7.26%
stock based compensation to revenue
0.00
-
0.00
7,451.65%
tangible asset value
11.79B
-
15.49B
31.36%
16.68B
7.65%
30.80B
84.71%
35.15B
14.11%
33.14B
5.71%
44.12B
33.12%
51.99B
17.85%
60.95B
17.23%
58.84B
3.47%
71.52B
21.56%
tangible book value per share
1.91
-
2.51
31.36%
2.70
7.65%
6.27
132.08%
5.59
10.80%
5.27
5.71%
7.02
33.12%
8.27
17.87%
9.70
17.25%
9.36
3.47%
11.38
21.56%
working capital
9.90B
-
18.80B
89.95%
16.63B
11.55%
22.82B
37.18%
21.46B
5.93%
25.00B
16.48%
26.27B
5.08%
24.49B
6.78%
35.29B
44.09%
34.13B
3.27%
44.34B
29.89%

All numbers in (except ratios and percentages)